A groundbreaking advancement in the treatment of geographic atrophy (GA), an advanced form of dry macular degeneration happened with the approval of pegcetacoplan, the first ever FDA-approved treatment for GA.

Georgeanna J. Klingensmith's generous bequest funds a professorship in pediatrics at Duke University School of Medicine.

Dean Mary Klotman talks to Donald McDonnell, PhD, the Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology about the FDA-approved breakthrough drug for breast cancer developed in his Duke lab.

The legacy of Black surgeons at Duke is recognized as Lisa McElroy, MD, MS, assistant professor of surgery and population health sciences, serves as the inaugural recipient of the Onyekwere E. Akwari, MD, Endowed Professorship which was created in honor of the first African American surgeon on staff at Duke.

One in seven men are diagnosed with prostate cancer during their lifetimes.

Duke obstetrician gynecologists discuss the impact of abortion restrictions on reproductive health care.

Meet the man behind the single largest commitment for financial aid ever made to the School of Medicine — $30 million to establish an endowment for need-based financial aid for medical students.

Five Duke University School of Medicine faculty members are among the 100 researchers elected to the American Society for Clinical Investigation (ASCI), one of the oldest and most esteemed nonprofi

Duke University School of Medicine was awarded more than $527 million in federal funding from the National Institutes of Health (NIH) in 2022, ranking ninth nationally among academic medical center